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ABSTRACT
Purpose The emergence of antimicrobial resistance 
has led to increasing efforts to reduce unnecessary use 
of antibiotics in primary care, but potential hazards from 
bacterial infection continue to cause concern. This study 
investigated how primary care prescribers perceive risk 
and safety concerns associated with reduced antibiotic 
prescribing.
Methods Qualitative study using semistructured 
interviews conducted with primary care prescribers from 
10 general practices in an urban area and a shire town in 
England. A thematic analysis was conducted.
Results Thirty participants were recruited, including 
twenty- three general practitioners, five nurses and two 
pharmacists. Three main themes were identified: risk 
assessment, balancing treatment risks and negotiating 
decisions and risks. Respondents indicated that their 
decisions were grounded in clinical risk assessment, but 
this was informed by different approaches to antibiotic 
use, with most leaning towards reduced prescribing. 
Prescribers’ perceptions of risk included the consequences 
of both inappropriate prescribing and inappropriate 
withholding of antibiotics. Sepsis was viewed as the most 
concerning potential outcome of non- prescribing, leading 
to possible patient harm and potential litigation. Risks 
of antibiotic prescribing included antibiotic resistant and 
Clostridium difficile infections, as well as side effects, 
such as rashes, that might lead to possible mislabelling as 
antibiotic allergy. Prescribers elicited patient preferences 
for use or avoidance of antibiotics to inform management 
strategies, which included educational advice, advice on 
self- management including warning signs, use of delayed 
prescriptions and safety netting.
Conclusions Attitudes towards antibiotic prescribing 
are evolving, with reduced antibiotic prescribing now 
being approached more systematically. The safety trade- 
offs associated with either use or non- use of antibiotics 
present difficulties especially when prescribing decisions 
are inconsistent with patients’ expectations.
INTRODUCTION
Inappropriate (AB) antibiotic prescribing is 
widespread but may bring risks for individual1 2 
and population health from drug side effects 
as well as from growing antimicrobial resis-
tance.3 Conversely, antibiotic avoidance may 
be associated with risks from serious bacterial 
infections that could be avoided through 
earlier treatment of infection episodes.2 Many 
studies have provided insights into the reasons 
for inappropriate antibiotic prescribing and 
several syntheses have been published,4–6 but 
the safety gradient associated with reducing 
antibiotic prescribing has developed as a new 
and highly relevant area of research. In this 
paper, patient safety is understood as ‘the 
avoidance, prevention and amelioration of 
adverse outcomes or injuries stemming from 
the process of healthcare’.7 The risks associ-
ated with antibiotic prescribing decisions are 
a key element of patient safety and require 
in- depth analysis. This paper addresses the 
gap in knowledge about prescribers’ percep-
tions of potential adverse outcomes associ-
ated with reduced antibiotic prescribing.
In the UK, primary care services account 
for nearly 80% of all medical antibiotic use 
but antibiotic utilisation in primary care has 
been declining in recent years and choice of 
antimicrobial agents has become more selec-
tive.8 9 A national target proposes a further 
reduction in antimicrobial use of 15% by 
202410 with antimicrobial resistance providing 
the rationale for the reduction in antibi-
otic prescribing. There were an estimated 
Strengths and limitations of this study
 ► The sample of participants was diverse, including 
different groups of primary care prescribers drawn 
from urban and rural settings.
 ► The views of respondents who participated in the 
study may not be representative of non- participating 
practitioners.
 ► Participant responses may have been influenced by 
the interview setting.
 ► Serious safety outcomes are infrequent and might 
not have been experienced by patients managed by 
participants in the study.
 ► The study may have limited transferability beyond 
high- income countries.
2 Boiko O, et al. BMJ Open 2020;10:e038851. doi:10.1136/bmjopen-2020-038851
Open access 
60 788 antibiotic resistant infections in England in 20189 
resulting from infection with diverse bacterial patho-
gens, additionally superinfection with Clostridium difficile 
may cause illness.11 The scale of antimicrobial resistance 
is increasing, especially across middle- income and low- 
income countries.12 Unnecessary exposure to antibiotics 
may also be associated with more immediate harms. 
As a result of prescribing in the community, antibiotic- 
associated adverse events including allergic reactions lead 
to many emergency visits with antibiotics accounting for 
up to 20% of hospital admissions from drug reactions 
in the USA.13 14 On the other hand, withholding antibi-
otics might potentially carry risks and reduced antibiotic 
prescribing in general practice is associated with a small 
increase in complications such as treatable pneumonia 
and peritonsillar abscess.2 15
The perceived priority of risks from either prescribing 
or not prescribing antibiotics requires a nuanced expla-
nation within the broader realm of professionals’ 
perceptions of safety and associated risk management. 
Fear of the risk of bacterial complications5 16 and prog-
nostic uncertainty about potential outcomes when not 
prescribing4 17 are reportedly among key factors that 
influence the prescription of antibiotics. Among hospital 
doctors, there is evidence that overtreatment is preferred 
to the potential for adverse patient outcomes from not 
prescribing.18 19 Klein et al20 and Broniatowski et al,21 for 
example, demonstrate that medical decision- making 
tends to favour views that favour prescription (‘why take 
risks’) rather than on prescription avoidance (‘antibiotics 
can be harmful’). In primary care, general practitioners 
(GPs) and other prescribers also deal with safety concerns 
in their decision- making, and a better understanding 
needs to be developed concerning the balance of risk 
between prescribing or non- prescribing of antibiotics.
Patient factors influencing decision- making on antibi-
otic prescribing include compliance with patient expec-
tations and pressures.16 22–24 Reducing AB prescribing in 
primary care is therefore highly dependent on successful 
management of patient expectations25–27 and on shared 
decision- making.28–31 It is known that clinicians weigh 
individual best practice against perceived patient satisfac-
tion so that complex trade- offs are enacted.32 Therefore, 
of research interest is also how the issues of safety and risk 
information are communicated to patients.
In the present study, we investigate how primary care 
prescribers perceive risk and safety concerns associated 
with reduced antibiotic prescribing.
METHOD
Study design
Semistructured interviews were conducted with primary 
care prescribers including GPs, nurses and pharmacists 
in two English regions, one an urban metropolitan area 
and the other shire town in England with a high demand 
for primary care services. The study was approved by 
London Hampstead Research Ethics Committee 18/
LO/1874 and participants gave written informed consent 
to participation.
Interviews
An interview guide was developed (box 1), this was 
designed to address key elements of the substantive 
research topic; it was also loosely informed by elements 
of the Theoretical Domains Framework, which draws on 
behaviour change theory to understand factors influ-
encing healthcare practice.33–35 The interview guide 
was piloted with three GPs to ensure that the questions 
were appropriate, understandable and covered relevant 
prescribing behaviours. All interviews were conducted by 
the first author to ensure consistent quality. The inter-
viewer has a PhD in medical sociology and is an experi-
enced qualitative researcher. All interviews apart from 
one telephone interview were conducted face to face on 
general practice (n=26) and University (n=4) premises 
Box 1 Interview guide
What are the indications for antibiotic (AB) treatment?
To what extent do NICE (National Institute for Health and Care Excellence) 
(or local) guidelines influence your AB prescribing?
What are the risks of AB prescribing and non- prescribing?
How do you differentiate between infections and patients?
What are the common myths or stereotypes about antibiotics?
Can you give me an example illustrating the inaccurate understanding 
of their purpose, mechanisms of action, risks and consequences?
In your view, is there the best way to elicit and manage patient expec-
tations regarding antibiotics?
How would you communicate the risks associated with both prescribing 
and non- prescribing antibiotics?
How confident are you in decision- making around AB prescribing?
Would you assess your approach to AB prescribing as always adequate 
and if so, what makes you think that?
Could you describe consequences of inappropriate treatment for 
infections?
What would be/were your actions following unresolved or repeated 
infections?
What is your understanding of antimicrobial resistance?
What are your goals and priorities in infection management?
Are there any social norms or group pressures that affect your profes-
sional practice with regards to AB prescribing and how?
Has your prescribing practice for antibiotics changed over the recent 
years?
Do you think patient expectations of AB treatment have changed over 
the recent years?
Are you aware of the prescribing practice of other HCPs (your col-
leagues) in relation to antibiotics? Have you ever had to challenge their 
prescribing decisions?
Has anyone challenged your own decisions?
How hopeful are you usually that the AB treatment is the best course 
of action?
Is it possible to assess both the short- term and long- term impact of AB 
treatment on the patients?
What is your decision- making strategy?
How anxious do you feel about the uncertainty around prescribing?
Which resources do you use to support your decisions on AB prescribing?
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in the period January to July 2019. The participants were 
offered £60 to acknowledge their contribution.
Recruitment of participants
Metropolitan practices were invited to the study by the 
local Clinical Research Network who generated the 
expression of interest. A shire town high- demand prac-
tice was recruited through informal Clinical Research 
Network contact that also helped in liaising with poten-
tial respondents. Potential participants were then 
approached either directly via email using the study 
information pack or indirectly via the practice manager 
or lead GP. The information pack included the invita-
tion letter and study information sheet. A reminder was 
sent out 2 weeks after the initial approach to those who 
had not responded. A purposive sampling approach was 
followed: all participants were prescribers. Forty- nine 
primary care prescribers from ten GP practices were 
invited and thirty agreed to take part. The sample size was 
determined using the pragmatic concept of ‘information 
power’,36 taking into account the aim of the study, sample 
specificity, quality of dialogue and analysis strategy. The 
uptake varied between practices (in five practices only a 
single participant was interviewed).
Analysis
The interviews were digitally recorded, transcribed by a 
professional transcriber, imported to an NVivo-12 project 
and coded through an iterative six phased process 
described in thematic analysis.37 Data analysis occurred 
iteratively and involved familiarisation, coding, theme 
searching, theme reviewing, theme defining and naming 
and producing the report. Repeated patterns in the data 
formed the basis for the codes, identified by the first 
author, and one single code for every different concept/
idea was generated. To ensure that codes were applied 
consistently, a co- author (CB) independently coded a 
random sample of four interview transcripts. Coding 
was refined after discussion. Data identified by the same 
code were collated together and all different codes were 
sorted into potential subthemes and themes using NVivo 
options of tree building. Then, the potential themes were 
reassessed and reorganised to reflect major narratives 
and themes in the coded data. Finally, the first, second 
and the last authors refined and named the themes and 
subthemes.
Patient and public involvement (PPI)
Participants’ feedback on the transcripts or the summarised 
final findings was not sought; however, the process of 
developing subthemes and themes was discussed at a PPI 
meeting. The purpose of the meeting was to inform the 
research of patient and service user perspectives. The 
meeting was attended by six PPI members including four 
women and two men of diverse ages. The preliminary 
findings were presented, and members were invited to 
discuss emerging themes and to review selected quotes 
from the interview transcripts for relevance. Feedback 
included comments on patient expectations, patient pres-
sure for antibiotics, trust and communication with GPs 
leading to additional interpretation.
RESULTS
We recruited 30 participants from 10 general practices 
(table 1. Characteristics of the participants), including 23 
GPs, 5 nurses and 2 pharmacists. The interviews lasted 
between 24 and 46 min. GPs’, nurses’ and pharmacists’ 
responses were analysed as a single group because of the 
many commonalities and smaller number of non- medical 
respondents. We found there were no discernible differ-
ences in participants’ accounts between the shire town 
and metropolitan settings. Overall, three participants 
expressed an overt avoidance of antibiotics, three others 
acknowledged overprescribing, while most prescribers 
leaned towards reduced prescribing. We distinguished 
three major themes from the data: risk assessment, 
balancing treatment risks and negotiating decisions and 
risks (table 2).
Theme 1: risk assessment
Identifying treatment thresholds
The primary focus of diagnostic decision- making for 
participants was concerned with identifying major indi-
cations for antibiotic treatment. These were judged 














Table 2 Summary of main themes and subthemes
Theme Subthemes
Theme 1: Risk assessment Identifying treatment thresholds
Confidence in prescribing
Theme 2: Balancing 
treatment risks
Risks of prescribing and non- 
prescribing
Facing antimicrobial resistance
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to include the nature and severity of illness based on 
presentation of symptoms and signs, in the context of 
the patient’s medical history. A majority of participants 
adopted a risk stratification approach in undertaking 
clinical assessment.
It’s a combination of things… For example, for an 
upper respiratory tract infection, tonsillitis, pharyn-
gitis, you know, there’s a Centor guidance. So that’s 
where you have a checklist of things. Does this person 
have cervical lymphadenopathy? Do they have a fe-
ver? Do they have like absence of a cough, you know. 
Do they have exudate on their tonsil? So, then if you 
have a score of 3 or more then they have antibiotics. 
(Int 1, GP).
Risk stratification approaches included additional 
patient factors such as patient age and the presence of 
comorbidities including COPD, asthma, diabetes, cancer 
or a history of pneumonia. Whereas, many followed risk 
assessment protocols based explicitly on local or national 
clinical guidelines, some participants stressed the impor-
tance of clinical judgement in making safety- driven 
decisions.
You don’t want to miss something very serious. So, 
that’s where your clinical judgement and decision- 
making skills play a major role. And experience, ob-
viously, because these are things I deal with every day. 
(Int 14, Nurse)
Threshold- guided decision- making spanned the 
continuum from ‘I am prescribing’ to ‘I am not 
prescribing’. Diagnostic uncertainty was part and parcel 
of the threshold- guided decision- making: prescribers 
pointed to the difference between more and less obvious 
cases, characterised by equivocal, ambiguous and non- 
convincing evidence. One participant contrasted several 
hypothetical scenarios:
‘…a patient with COPD, bronchiectasis, I may have 
a lower threshold for treating than a very fit and well 
20- year- old, even if that 20- year- old had a productive 
cough with green sputum, their chest is clear, I’m not 
likely to give them antibiotics. Well they’re not fever-
ish, whereas if they’re an 80 something with a history 
of COPD then I’d have a lower threshold for starting 
antibiotics because they’re likely to have less reserve 
and more likely to have complications from an infec-
tion’ (Int 20, GP).
Confidence in prescribing
Appropriate prescribing and not just a reduction in antibi-
otics emerged as a priority for participants, who reflected 
on their own performance from different perspectives. In 
general, participants reported a high level of confidence 
in prescribing but also noted occasional limitations:
I feel confident but that doesn’t mean necessarily 
that I think I’m making the right decision in every 
case. Sometimes when I’m making perhaps the wrong 
decision, I’m making that maybe because of patient 
pressure or because of my unwillingness to tolerate 
risk. (Int 22, GP).
Many participants acknowledged changes towards less 
prescribing over the last few years:
I prescribe less because I guess we’re more aware now 
of drug resistance than we were 5 years ago. It’s much 
more talked about and we’re seeing it more. But also, 
I’m now more confident in having that difficult dis-
cussion with the patient. (Int 5, GP)
Theme 2: balancing treatment risks
Risks of prescribing and non-prescribing
Seven participants explicitly identified safety as a priority 
in infection management. All participants demonstrated 
vigilance to risks arising both from prescribing antibi-
otics and not prescribing. The fear was expressed of 
‘missing something’ that could cause deterioration and 
consequently, participants admitted ‘being cautious’ and 
favoured prescribing antibiotics. At the same time, the 
common concern was also the avoidance of prescribing 
unnecessarily. Among the risks of prescribing, several side 
effects were reported, most commonly, gastrointestinal 
upsets, nausea, Clostridium difficile infection and thrush 
but also allergic, anaphylactic reactions, antibiotic resis-
tance and less common side effects such as liver problems 
(failure). Participants also observed long- term adverse 
consequences of inappropriate prescribing:
I think, certainly for children, I think if you prescribe 
antibiotics and they don’t need them and then they 
have a rash because they’ve got a virus and then a 
penicillin allergy on their notes for the rest of their 
lives… I think another consequence is that if you pre-
scribe inappropriately, it’s very difficult for another 
healthcare professional, down the line, to explain to 
that patient, you’re almost saying the other person 
was wrong. (Int 15, Nurse)
Risks of non- prescribing generated a shorter list with 
sepsis being the most concerning consequence.
Sepsis…that’s one thing I do worry about. If I see 
someone who’s got a high temperature and a high 
heart rate… then I think about those factors and I 
think actually if this was in my clinical judgement – if 
I left this for 2 days, then I think they would be cross-
ing that line (Int 26, GP).
Three prescribers who acknowledged the tendency to 
overprescribe, did so, in one case, because they assessed 
antibiotics’ benefits to exceed harms and in two cases 
because of potential litigation following a missed serious 
bacterial infection:
Because medico- legally you’re much more likely to be 
brought up on missing something and not prescrib-
ing antibiotics than giving antibiotics when it wasn’t 
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necessary… if there’s any uncertainty about prescrib-
ing antibiotics I would always err on the side of giving 
them because the risk, however small of missing an 
infection that then gets worse would be enough for 
me to give antibiotics. (Int 19, GP)
Facing antimicrobial resistance
Participants shared concern for the global rise in antimi-
crobial resistance. At the same time, they acknowledged 
lacking in- depth microbiological knowledge: “we talk 
more about not prescribing and prescribing correctly 
than resistance itself’ (Int 9, Pharmacist). Meanwhile, 
they had to deal with the consequences of the antimicro-
bial resistance in their daily practice:
I’ve had a few patients that have had MRSA 
[Methicillin- resistant Staphylococcus aureus]. 
I’ve had a few people who have had PVL [Panton- 
Valentine leukocidin form of MRSA] infections, skin 
infections with multiple resistance… So we can some-
times struggle to find an antibiotic that’s oral, that’s 
then suitable. I’ve got a Type 1 diabetic, young lady, 
who has very poorly controlled diabetes and recur-
rent boils and abscesses on her back. And we did a 
swab of that and yes, there was only one oral antibi-
otic that was sensitive - everything else was resistant. 
(Int 23, GP)
antimicrobial resistance was most commonly encoun-
tered in older women with urinary tract infections:
‘I think sometimes you do see, for example, in the 
UTI breakdown, some people have quite resistant 
UTIs and that becomes difficult’. (Int 15, Nurse)
‘I’ve been a GP for about 10 years and you’ve already 
seen that certain antibiotics just aren’t working any-
more, and we need to change the way that we’re do-
ing things and you know we used to give trimethoprim 
locally first line for UTIs. Resistant in the majority of 
cases. So, we’re giving nitrofurantoin’. (Int 10, GP)
There was mention of difficulties in conveying infor-
mation about resistance to patients—discussing it in the 
encounters and emphasising community impact may 
have been less efficient than focussing on individual risks. 
There was also a worry that primary care is running out of 
antibiotics despite the strategies of second- line and third- 
line antibiotics:
They (patients) literally cannot have any, they’ve got 
an E. coli infection that’s not sensitive to amoxicillin 
or nitrofurantoin or trimethoprim or even cefalexin 
or the cipro. It’s just like literally multiply- resistant. 
And there’s some quite virulent, my understanding is 
it is strains of bacteria where antibiotics will not work. 
And then you kind of get to the hard- core ones. (Int 
11, GP)
In such cases of failure of several course of antibi-
otics, referral to secondary care, possibly for intravenous 
therapy were reported as the only options. Other times, 
where the resistant organism could be tackled in primary 
care, the last resort was a longer course or long- term 
prophylactic antibiotics. More investigations and consul-
tations with microbiologists about unresolved infections 
appeared to precede these decisions.
Theme 3: negotiating decisions and risks
Managing patient expectations
Participants identified patient pressure as a factor in their 
decision- making but they shared the view that patients 
differ in terms of their expectations regarding antibiotics. 
On the one hand, increased knowledge of the appro-
priate indications for antibiotic therapy (not for viruses) 
and understanding of antimicrobial resistance from 
public health and media campaigns was noted. On the 
other hand, patient pressure in a form of implicit expec-
tations or explicit demands remained frequent: readily 
prescribed in the past, antibiotics had a profile of imme-
diate cure in large parts of patient population:
… so many people have been mis- prescribed antibiot-
ics in the past that I think they just won’t believe you 
that they don’t need them (Int 25).
A GP summarised this ambivalence:
There’s a reasonable cohort now who come in and 
say they don’t want them (antibiotics). They’ve read, 
they’re educated, they know that they’re contributing 
potentially to resistance and they don’t want to risk 
the side effects. But there’s also a large cohort still 
who come in and say, “My cough’s gone to my chest, I 
need antibiotics. So, it’s trying to often you know, get 
through those barriers and explain to them that their 
chest is clear.” (Int 10, GP)
Eliciting expectations, educating patients and delayed 
prescription were the key strategies for managing patient 
expectations. Explaining assessment results and positive 
language were deemed important for the success of the 
consultation; several participants preferred the time- 
saving mode of giving out written information about the 
expected length of illness (for example, about the dura-
tion of sinusitis with and without antibiotics) and about 
side effects of antibiotics. Elicitation of expectations 
included asking patients: “What were you hoping for when 
you came in today?” (Int 26, GP). Delayed prescriptions 
were used by all but three of the participants interviewed. 
This was considered as a form of partnership, of shared 
decision- making between the clinician and the patient:
… that helps patients because at least psychologically 
they have got an antibiotic, but they know they can’t 
use it straightaway. (Int 25, GP)
Communicating risks
As above, participants demonstrated that the commit-
ment to reduced prescribing was dependent on patient 
understanding of the need for antibiotics. This meant 
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that at times building and maintaining relationships were 
prioritised and led to prescribing decisions, as an inter-
viewee reported:
Much of my job is trying to build a rapport with some-
one and build a rapport so that we can have a con-
versation that’s therapeutic. If someone has come in 
adamant that they want antibiotics there is some con-
versation to be had there. Why did you get this idea 
from? What is it that you believed this would do? And 
what is your previous experience? Now, if they’re not 
willing to go into that today, I may actually give them 
a short course of antibiotics with the understanding 
that we have another conversation. This is a way of 
building some trust (Int 29, GP).
The participants differed in terms of how they dealt 
with risk in encounters with patients: some were liberal 
prescribers who tended to avoid complaints and patient 
frustration, others preferred having difficult conver-
sations on non- antibiotics’ course of actions. Among 
liberal prescribers, there was the notion of offering anti-
biotics in order to be safe. In the case of non- prescribing, 
prescribers sometimes delved into lengthy explanations 
in order to secure patient adherence:
When I’m explaining that there’s no sign of bacterial 
infection and we don’t want to give you antibiotics if 
we don’t need to. Most people go, ‘Oh yes, yes, no, 
of course not.’ But some people might say, ‘Oh, well, 
you know.’ Then I will go into the reasons why, you 
know. ‘Well actually you might get side effects, you 
know, it can make you, give you diarrhoea, it can give 
you thrush. And things can become resistant to it and 
it won’t be helpful for you in the future. (Int 30, GP)
Advice on possible warning signs: ‘safety netting’ 
emerged as a dominant risk reduction strategy:
I will give them (patients) an awful lot of safety- 
netting, and tell them what, ‘If this doesn’t get better, 
this is when you come back.’ You know, or ‘These are 
the signs of you getting worse,’ or what they do if they 
are getting worse. (Int 16, GP)
DISCUSSION
Main findings in comparison with previous research
The study describes primary care prescribers’ percep-
tions of safety and associated trade- offs in the context 
of reduced antibiotic prescribing. We identify three key 
themes with relevance to safety: risk assessment, balancing 
treatment risks, and negotiating decisions and risks. These 
accounts from primary care demonstrated variations in 
prescribers’ approaches to decision- making behaviour, 
including perceptions of risks associated with prescribing 
or not prescribing antibiotics and in the communication 
of these decisions and risks to patients.
Decision- making for appropriate antibiotic 
prescribing was informed by safety considerations. 
Guideline- concordant risk assessment was generally 
preferred to tacit clinical judgement based on informal 
heuristics in line with previous research38 Confidence in 
prescribing can be contrasted with views that accentuate 
diagnostic uncertainty.4 17 In complex or uncertain cases, 
resolution was usually in favour of antibiotic prescribing, 
but this was in the context of a secular shift to generally 
more restrictive antibiotic prescribing behaviour. The 
reduction imperative coexists with liberal prescribing, 
which was influenced by low tolerance of risks and 
patient pressures. This corresponds with extant literature 
that identifies the coexistence of different prescribing 
behaviours including antibiotic compromising, antibiotic 
delaying and antibiotic withholding.24
Safety trade- offs emerged from the respondents’ 
perceptions of risk by lending support to recent qualita-
tive research, which reported the complexity of balancing 
risks of antibiotic prescribing in hospitals.39 In addition 
to anticipated benefits, respondents identified multiple 
risks associated with either prescribing or not prescribing 
antibiotics, so that the immediate and long- term adverse 
effects of prescribing, including antimicrobial resistance, 
were weighed against potential complications of non- 
prescribing such as sepsis. These untoward consequences 
rendered risk a double- edge sword. In the theory of social 
systems, such a conundrum can be described by the 
distinction risk/danger, rather than risk/safety because 
there is no absolute safety in prescribing decisions, hence 
the other side of risk remains danger not safety.40 41 From 
Luhmann’s40 perspective, some distinctions are two- sided 
forms of ‘second- order’ observations, where one side is 
actualised at any given moment, but both sides may have 
equal relevance to the situation. Risk/danger represents 
such a form which exemplifies the contingency associ-
ated with seemingly binary choices, but which in itself 
represents actuality versus potentiality. According to this 
perspective, safety experts are ‘first- order’ observers who 
may not account for the mutuality of contingency because 
the other side is always present on the background. Boiko 
et al41 applied this understanding to the analysis of clinical 
risks associated with anticoagulant prophylaxis, where risks 
of thrombosis were complemented by dangers of contra-
indications (eg, bleeding). In our situation of antibiotic 
prescribing, the ‘risk’ side is associated with prescribing 
potentially resulting in antimicrobial resistance and side 
effects, while the other side (danger) can be actualised 
if non- prescribing is chosen and can become the actual 
risk through complications such as sepsis. We found vari-
ation in how the prescribers perceived this duality, with 
the safety argument contributing in both directions: 
prescribing and non- prescribing. In other words, profes-
sionals’ acting on ‘doing something’ were juxtaposed 
against ‘doing no harm’ concerns. The participants were 
able to distinguish between short- term (eg, side effects) 
and long- term (eg, antimicrobial resistance, effect on 
doctor–patient relationship) trade- offs of prescribing. 
Antimicrobial resistance was generally viewed as a stand-
alone long- term adversity now being encountered in daily 
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practice; it is gaining in prominence in contrast to find-
ings from the earlier qualitative studies42 43 and now has 
a more personalised relevance and clinical significance 
than some recent reviews suggested.44
Respondents negotiated safety in dealing with patients 
by rendering medical decision- making more explicitly 
during consultations. Patient expectations were found 
to be changing and so were the strategies employed in 
managing them. There was an emerging consensus on 
strategies to reduce antibiotic prescribing including 
patient education, improved self- management advice 
and delayed prescribing, supported by patient- centred 
communication emphasised in the other literature too.45 
At the same time, our study showed communication 
was primarily centred on warning signs, and on main-
taining a clinician–patient relationship, rather than on 
the discussion of risks and benefits with patients. This is 
consistent with previous findings that explicit analysis of 
trade- offs is most often undertaken by physicians alone 
rather than as part of a dialogue with patients.46 More 
explicit risk communication might become a focus of the 
consultations for (bacterial) infections. Systematic review 
evidence suggests that shared decision- making reduces 
prescribing47 and our study also found that both delayed 
prescribing48–51 and safety- netting appeared as effective 
strategies of shared decision- making.
Strengths and limitations
The study provided a coherent analysis of the views of 
primary care prescribers drawing on the responses of 
participants working in rural and urban settings and 
including a sample that was diverse with respect to profes-
sional training and years of experience. The size of the 
sample may not have been sufficient to distinguish differ-
ences in approach between groups with different profes-
sional training, but this could be explored further in 
future studies. The study may possibly have reduced trans-
ferability to other settings beyond UK primary care or 
beyond high- income countries. Participants were neces-
sarily informed of the nature and purpose of the research, 
consequently both their participation in the interview 
and the interview responses might have been influenced 
by research participation. It is possible that respondents 
who were less inclined to reduce antibiotic prescribing 
might have been less prepared to participate. Interview 
responses might have been inclined to give what they 
perceived as ‘socially acceptable’ responses. We employed 
a thematic analysis because this enables a flexible investi-
gation of a complex topic without drawing on pre- existing 
theory. In order to reduce the possibility of inconsistency, 
we employed a systematic, staged approach to analysis 
and a sample of transcripts was repeat coded by a second 
analyst. A patient group was involved in the research, but 
we acknowledge that patient involvement contribution 
must be managed carefully to avoid introducing bias. The 
thematic analysis was completed by experienced qualita-
tive researchers using participant data; PPI input did not 
in this case lead to any modification of themes identified. 
It might be argued that if the PPI group did not mate-
rially influence the eventual data presentation, then the 
information about PPI involvement could be removed 
from the paper. However, the funders, the journal and 
the authors remain committed to the importance of PPI 
and have retained the PPI statement. This paper should 
be read in conjunction with our companion study, which 
explored the views of patients as participants.52
Implications for further research and practice
This study explored and characterised primary care 
prescribers’ perceptions of safety issues and risk manage-
ment strategies relevant to reduced antibiotic prescribing. 
The study offers insights into primary care prescribers’ 
perceptions and as such it emphasises the safety perspec-
tive within the current debate on antibiotic prescribing and 
antimicrobial stewardship. The study identified dilemmas 
that are recognisable in the course of daily primary care 
practice and can form the basis for future improvement 
and antimicrobial stewardship programmes. Our research 
paves the way for a cross- sectional survey of risk percep-
tions. It highlights the need for further development of 
risk stratification and risk communication tools such as 
decision- making checklists and evidence- based support 
tools. It also stresses the need for adequate training on 
antimicrobial resistance and reducing of antibiotics (such 
as GRACE- INTRO and REDUCE).53 54 Safety netting had 
a strong presence in the interviews, however, as such is 
under- researched and requires further exploration. Our 
findings support the argument31 that prescribers need 
more time to discuss the benefit–harm trade- off within 
shared decision- making as this may help to reduce antibi-
otic prescribing in primary care.
CONCLUSIONS
Attitudes towards antibiotic prescribing are changing 
and becoming more nuanced. There is growing confi-
dence in the capacity to reduce the rate of prescribing 
and to manage patient expectations, which are them-
selves undergoing change. There is growing recognition 
that there may be safety trade- offs associated with antimi-
crobial stewardship and this is linked to concerns about 
sepsis and other serious bacterial infections. There is a 
need to develop better quantified estimates of risk that 
can inform clinical decision- making and ‘safety netting’ 
advice given to patients. This will require further devel-
opment of risk stratification estimates, as well as commu-
nication tools that enable these to be used in practice. 
Improved management of risks and benefits will help to 
inform future antimicrobial stewardship efforts.
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